Skip to content

A Randomized Placebo Controlled Trial on the Efficacy of Sustained Natural Apophyseal Glide (SNAG) in Low Back Pain Patients

Immediate and Short-term Effects of Mulligan Sustained Natural Apophyseal Glides for a Subgroup of Low Back Pain Patients: A Randomized Placebo Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02128607
Enrollment
32
Registered
2014-05-01
Start date
2014-02-28
Completion date
2014-07-31
Last updated
2014-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain, Manual Therapy, Sustained Natural Apophyseal Glide (SNAG)

Keywords

low back pain, manual therapy, Mulligan, sustained natural apophyseal glide (SNAG), Kinematic spine model

Brief summary

Objectives: Determine the efficacy of the SNAG technique (Mulligan) applied to a subgroup of people with non-specific low back pain (LBP) on two new kinematic-algorythms, on pain, functional disability and kinesiophobia. Design: A randomized double blinded placebo controlled trial with double arms in accordance with the CONSORT statement. Subjects: Patients with non-specific low back pain will be recruting from Saint-Luc hospital, only a subgroup of them will be included according to specific inclusion criteria tailored for indication of application of SNAG's therapy (Mulligan technique applied on the lumbar spine). Method: Subjects will be randomized in 2 groups; real-SNAG and sham-SNAG groups. All patients will be treated during a single session, and real/sham SNAG will be applied from a sitting position with the belt, and in a flexion direction. Two kinematic-algorythms (ROM and Speed) from a validated kinematic spine model will be used and recorded with an opto-electronic device (BTS-Elite). Pain at rest and during flexion, as well as functional disability and kinesiophobia will be recorded by self-reported measures. These outcomes will be blindly evaluated before and after treatment to compare both groups with Two-Way-ANOVA statistic with for factors; time and groups.

Interventions

DEVICESNAG

sustained natural apophyseal glide: SNAG / Mulligan technique

DEVICESham

Sponsors

Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* non-specific LBP, mechanical LBP with a pain in flexion direction, the pain in flexion is reduce with the application of SNAG therapy

Exclusion criteria

* specific LBP, non-mechanical LBP, the pain is not release in a flexion direction when SNAG is appllied

Design outcomes

Primary

MeasureTime frameDescription
Kinematic spine model (Hidalgo et al 2012 Journal of rehabilitation medicine)Change from baseline until discharge of treatment (same day, single session)Use of quantitative variables for ROM and SPEED kinematic (Logit scores index)

Secondary

MeasureTime frame
Oswestry Disability questionnairechange from baseline until 2 weeks after treatment
present pain with visual analog scale (VAS)change from baseline and after treatment the same day (single session)
Tampa scale for kinesiophobiachange from baseline until two weeks after treatment

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026